News

The Only Agency's Innovative Sports Division Launch

The Only Agency's Innovative Sports Division Launch

The Only Agency Unveils Its New Sports Division

The Only Agency, a leader in the talent agency sector, has recently announced the launch of its innovative sports division. This strategic move focuses on merging the realms of sports and fashion, creating fresh opportunities to bridge the gap between these interconnected industries.

Leadership Steering the New Division

At the helm of this exciting new venture is Bernard Tyler, a veteran in sports and entertainment marketing with over a decade of experience. Tyler, who previously worked with prominent agencies such as WME and CAA, brings a wealth of knowledge and strategic insight to The Only Agency. His impressive track record includes aligning high-profile talent with global brands like Coca-Cola and Chase, making him a perfect fit for this role.

Collaborative Approach to Sports and Fashion

Tyler will collaborate closely with Kent Belden, CEO and founder of The Only Agency, and Senior Director of PR and Brand Partnerships, Brett Decker. Together, they aim to provide comprehensive representation services that encompass talent management, brand partnerships, and publicity across a variety of platforms.

Vision and Goals for the Division

In a statement, Tyler expressed his enthusiasm about joining The Only Agency, highlighting their commitment to being ahead of market trends. He aims to harness this energy to revolutionize the sports sector, connecting talented individuals with athlete-driven brands to craft compelling narratives that blend fashion with culture.

Showcasing Athletes as Influencers

The agency's sports division is set to synergize efforts with teams specializing in styling, beauty, and photography to further integrate the worlds of sports and fashion. This approach reflects the understanding that athletes significantly influence these industries. Noteworthy collaborations have already taken place, featuring stars such as Lewis Hamilton, Lionel Messi, and Serena Williams, showcasing their impact on events like the MET Gala and the Super Bowl.

Behind the Strategy

Kent Belden emphasizes the agency's long-recognized potential of athlete-driven artists in shaping various sectors. With Tyler's vast expertise combined with the team's existing knowledge of fashion and beauty, The Only Agency is poised to maintain its high standards of service while addressing the increasing demands in sports.

About The Only Agency

Founded in 2014, The Only Agency has quickly established itself as a leading force within the talent representation field. With locations in major markets including New York and Los Angeles, the agency is dedicated to representing a diverse array of talent, including celebrity fashion stylists and production designers. Their roster is a testament to the creativity and inspiration that shapes the fashion and beauty landscape.

Contact Information

For media inquiries, please reach out to Khortlyn Cole, Press Manager at The Only Agency. You can contact her at (310) 435 - 7906.

Frequently Asked Questions

What is the primary focus of The Only Agency's new sports division?

The new sports division aims to connect the worlds of sports and fashion, enhancing athlete representation and collaboration within these industries.

Who is leading the sports division at The Only Agency?

Bernard Tyler, with extensive experience in sports marketing, is leading the initiative, supported by the agency's executive team.

What types of services will the sports division provide?

The division will offer full-service representation, including talent management, brand partnerships, and publicity efforts.

How has The Only Agency previously engaged with athletes?

The agency has collaborated with renowned athletes like Lewis Hamilton and Serena Williams, significantly participating in major events and campaigns.

Where is The Only Agency located?

The Only Agency has offices in New York, Los Angeles, Nashville, and London, serving a global clientele.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading

Top 5 Most Recently Viewed Articles

Dorman Products: Anticipating Positive Earnings Ahead

Updated Category News Views 264

Optimistic Earnings Outlook for Dorman Products Dorman Products (NASDAQ: DORM) is gearing up to announce its quarterly earnings report soon, generating buzz among investors. The anticipated release date is approaching, and many are keen to see how the company performs. Expectations Surrounding EPS Analysts have set expectations high, forecasting an earnings per share...

Continue Reading
Fission Uranium Corp. Publishes Results from Special Meeting

Updated Category News Views 53

Fission Uranium Corp. Shares Results from Special Meeting Fission Uranium Corp. (TSX: FCU, OTCQX: FCUUF) recently conducted an important meeting with its securityholders. During this special meeting, the company revealed the results of key votes that will shape its future direction and partnership strategies. Shareholders Express Strong Support for Key Resolutions At the...

Continue Reading
Prevounce Health Enhances Integration with Elation Health's EHR

Updated Category News Views 173

Prevounce Health Partners with Elation Health for Enhanced Care The integration between the Prevounce remote care management platform and the Elation electronic health record (EHR) system marks a significant advancement in healthcare technology. This partnership aims to streamline healthcare processes and enhance patient care through technological synergy. Understanding...

Continue Reading
Exploring the Expanding Landscape of Social Media Listening

Updated Category News Views 196

Growing Demand for Social Media Listening The social media listening market is experiencing remarkable growth, expected to surge from USD 8.36 billion in 2023 to USD 27.63 billion by the year 2032. This projection represents a compound annual growth rate (CAGR) of approximately 14.27% during the forecast period. The increasing need for real-time insights into consumer...

Continue Reading
Orthopedic Braces Market Set to Surge to $5.5 Billion by 2030

Updated Category News Views 123

Overview of the Orthopedic Braces and Supports Market The global orthopedic braces and supports market is currently experiencing significant growth, with a valuation of approximately US$3.8 billion in 2024. This market is expected to reach US$5.5 billion by 2030, showcasing a compound annual growth rate (CAGR) of 6.5% across this period. One of the primary factors...

Continue Reading